UBS Maintains Neutral on Xponential Fitness, Lowers Price Target to $4.5

Benzinga · 2d ago
UBS analyst Arpine Kocharyan maintains Xponential Fitness (NYSE:XPOF) with a Neutral and lowers the price target from $7 to $4.5.